Genomes.io
London, United Kingdom
Genomes.io believes that individuals should be able to own, control access to and benefit from their most sensitive and valuable personal asset, their DNA. Genomes.io is building a secure DNA sequencing, storage and sharing technology using state-of-the-art encryption and blockchain technologies to provide users with control over their whole genome sequence. This allows users to control access to segments of their genome in a repeat consent model to trusted professionals and accredited researchers in a secure, private and anonymous manner. Their platform acts as genomic data aggregator that provides research organisations with a more efficient genomic data acquisition model. They do so in a more equitable model in which individuals own, control and get paid for the data they wish to share. Genomes.io aims to securely sequence and store 1 billion individual’s genomes in our DNA data bank and become the world’s largest, most secure and trusted genomic and health data marketplace to power the personalised medicine revolution.
Company Info
- Founded
- 2017
- Website
- genomes.io/
Only accessible to MedStartr community members.
Join nowWhat do you think of Genomes.io?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.